|
DEOXYCHOLIC ACID
 INN DEOXYCHOLIC ACID
|
cas 83-44-3 |
CLASS DERMATOLOGICAL CYTOLYTIC DRUG DESTROYS THE CELL MEMBRANE CAUSING LYSIS TREATMENT OF MODERATE TO SEVERE CONVEXITY OR FULLNESS ASSOCIATED WITH SUBMENTAL FAT |
|
NATURAL MOLECULE (link) ATC code
D11AX24 |
PK parameters Tmax 0.3 HOUR Cmax 2.6 MICROMOLAR PPB 98 PERCENT
|
Target- PDB OBSOLETE (- 1WB2 CRYSTAL STRUCTURE OF TRANSLATION ELONGATION FACTOR SELB FROM METHANOCOCCUS MARIPALUDIS, APO FORM) Ligand code = DXC (link to the list of PDB complexes) Download experimental 3D coordinates of DXC with added hydrogens |
DrugCentral Unknown |
Download SDF file |
Cholan-24-oic acid, 3,12-dihydroxy-, (3alpha,5beta,12alpha)- Formula: C24H40O4 Calculated chemical properties: MW 391.55 NB_atoms 28 XLogP 3.14 PSA 76.045 NB_HD 2 NB_HA 4 fsp3 0.96 Lipinski(0=no;1=yes) 1 |
FDA NDA 206333 ( label) INN (DEOXYCHOLIC ACID) KYBELLA (ABBVIE) APPROVAL= AP YEAR= 2015 NDA 212296 (pdf not found) INN (DEOXYCHOLIC ACID) DEOXYCHOLIC ACID (WILSHIRE PHARMS INC) APPROVAL= AP YEAR= 2021 |
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |